Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 29376 | 153 | 19.6 | 46% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2717 | 2782 | INCOMPATIBILITIES//AMERICAN JOURNAL OF HOSPITAL PHARMACY//PSEUDOLITHIASIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BUREAU BARRIERE SYNDROME | Author keyword | 2 | 50% | 2% | 3 |
| 2 | RETROGRADE VENOUS PERFUSION | Author keyword | 2 | 43% | 2% | 3 |
| 3 | FB RATIO | Author keyword | 1 | 100% | 1% | 2 |
| 4 | PLASMA COMPATIBILITY | Author keyword | 1 | 100% | 1% | 2 |
| 5 | DITEKIREN | Author keyword | 1 | 33% | 1% | 2 |
| 6 | FLOW TESTING | Author keyword | 1 | 50% | 1% | 1 |
| 7 | HEMOLYTIC POTENTIAL | Author keyword | 1 | 50% | 1% | 1 |
| 8 | IMXLMOM | Address | 1 | 50% | 1% | 1 |
| 9 | MARFAN CLIN | Address | 1 | 50% | 1% | 1 |
| 10 | PERFORATING ULCER | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BUREAU BARRIERE SYNDROME | 2 | 50% | 2% | 3 | Search BUREAU+BARRIERE+SYNDROME | Search BUREAU+BARRIERE+SYNDROME |
| 2 | RETROGRADE VENOUS PERFUSION | 2 | 43% | 2% | 3 | Search RETROGRADE+VENOUS+PERFUSION | Search RETROGRADE+VENOUS+PERFUSION |
| 3 | FB RATIO | 1 | 100% | 1% | 2 | Search FB+RATIO | Search FB+RATIO |
| 4 | PLASMA COMPATIBILITY | 1 | 100% | 1% | 2 | Search PLASMA+COMPATIBILITY | Search PLASMA+COMPATIBILITY |
| 5 | DITEKIREN | 1 | 33% | 1% | 2 | Search DITEKIREN | Search DITEKIREN |
| 6 | FLOW TESTING | 1 | 50% | 1% | 1 | Search FLOW+TESTING | Search FLOW+TESTING |
| 7 | HEMOLYTIC POTENTIAL | 1 | 50% | 1% | 1 | Search HEMOLYTIC+POTENTIAL | Search HEMOLYTIC+POTENTIAL |
| 8 | PERFORATING ULCER | 1 | 50% | 1% | 1 | Search PERFORATING+ULCER | Search PERFORATING+ULCER |
| 9 | RENIN INHIBITOR PEPTIDE | 1 | 50% | 1% | 1 | Search RENIN+INHIBITOR+PEPTIDE | Search RENIN+INHIBITOR+PEPTIDE |
| 10 | THERAPEUTIC SUCCESS | 1 | 25% | 1% | 2 | Search THERAPEUTIC+SUCCESS | Search THERAPEUTIC+SUCCESS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AMIODARONE INDUCED PHLEBITIS | 3 | 100% | 2% | 3 |
| 2 | DITEKIREN | 3 | 60% | 2% | 3 |
| 3 | PURINE CONTENT | 1 | 50% | 1% | 1 |
| 4 | INTRAVENOUS USE | 0 | 12% | 2% | 3 |
| 5 | EICOSANOID METABOLISM | 0 | 11% | 2% | 3 |
| 6 | CREMOPHOR EL MICELLES | 0 | 25% | 1% | 1 |
| 7 | INTRAARTERIAL TREATMENT | 0 | 17% | 1% | 1 |
| 8 | SOLCOSERYL | 0 | 17% | 1% | 1 |
| 9 | RETROGRADE VENOUS PERFUSION | 0 | 11% | 1% | 1 |
| 10 | PROPHYLACTIC CEFAZOLIN | 0 | 10% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Formulation-related problems associated with intravenous drug delivery | 1998 | 48 | 28 | 54% |
| Amiodarone-Induced Thrombosis: A Case Series and Brief Review of the Literature | 2012 | 1 | 7 | 57% |
| CLINICAL-FEATURES AND THERAPY OF BUREAU-BARRIERE SYNDROME - OBSERVATIONS IN 17 CASES WITH REVIEW OF LITERATURE | 1993 | 11 | 4 | 75% |
| Developing early formulations: Practice and perspective | 2007 | 60 | 51 | 16% |
| Intravenous administration of poorly soluble new drug entities in early drug discovery: The potential impact of formulation on pharmacokinetic parameters | 2002 | 38 | 63 | 8% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMXLMOM | 1 | 50% | 0.7% | 1 |
| 2 | MARFAN CLIN | 1 | 50% | 0.7% | 1 |
| 3 | SERV MED SECC REUMATOL | 1 | 50% | 0.7% | 1 |
| 4 | LUDWIG BOLTZMANN CARDIOTHORAC SURG | 0 | 33% | 0.7% | 1 |
| 5 | ST JOSEPH REG MED | 0 | 33% | 0.7% | 1 |
| 6 | DMPK DISCOVERY SUPPORT | 0 | 25% | 0.7% | 1 |
| 7 | GERIATR ABT | 0 | 25% | 0.7% | 1 |
| 8 | ASSESSMENT REMEDIAT READY POINT NURSING | 0 | 100% | 0.7% | 1 |
| 9 | CARDIAC SURVEILLANCE UNIT | 0 | 100% | 0.7% | 1 |
| 10 | DIAGNOST LB CELLULAR BIOCHEM | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000089568 | SOLCOSERYLR//WOUND HEALING DRUGS//ACTOVEGIN |
| 2 | 0.0000084419 | 4150 CLEMENT ST//MED COLUMBIA//AEROBIC WORK CAPACITY |
| 3 | 0.0000083627 | NANOSUSPENSION//NANOSUSPENSIONS//WET MEDIA MILLING |
| 4 | 0.0000078577 | INCOMPATIBILITIES//DEXTROSE//SPANISH CANC ASSOC |
| 5 | 0.0000077075 | TROSPECTOMYCIN//CLIN SCI AGR PRACTICES//ANAEROBIC SUSCEPTIBILITY |
| 6 | 0.0000073190 | CAS 88931 51 5//MONOLAYER BILAYER EQUILIBRIUM//PARENTERAL EMULSIONS |
| 7 | 0.0000071729 | LONG ACTING OXYTETRACYCLINE//LOCAL TOLERANCE//CAS 24390 14 5 |
| 8 | 0.0000070444 | ACAENA SPLENDENS//PROPYLENE GLYCOL TOXICITY//OSMOLAR GAP |
| 9 | 0.0000067852 | EXPT THER EUT PHARMACOINFORMAT//PROSTACYCLIN SYNTHASE GENE//PROSTACYCLIN SYNTHASE |
| 10 | 0.0000063449 | IMEXON//1 4 DIHYDRO 2 3 QUINOXALINEDIONE//CYANOAZIRIDINE |